Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

July 01, 2007 (Vol. 27, No. 13)

Increasing Capacity for GMP Peptides

Expanding Targets and Novel Drug Delivery Strategies Drive Manufacturing Demands

  • With an annual growth of greater than 15%, an increasing number of new projects, and a growing number of peptide drug candidates moving into late-stage clinical trials, the GMP peptides market remains strong. Rising interest in therapeutic peptides among big pharma, driven by an expanding number of new drug ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.